16,17-(((R)-3-CYCLOHEXEN-1-YLMETHYLENE)BIS(OXY))-11-HYDROXY-21-(2-METHYL-1-OXOPROPOXY)-PREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII 3H5ZUU5SZ8
Substance Identification & Data
This profile provides standardized clinical and technical data for 16,17-(((r)-3-cyclohexen-1-ylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3H5ZUU5SZ8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3035286-86-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H42O7 KYVYPETUNWCRSM-YPBIWXILSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 16,17-(((r)-3-cyclohexen-1-ylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.